The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 24, 2021

Filed:

Nov. 02, 2017
Applicant:

Axon Neuroscience SE, Cyprus, CY;

Inventors:

Michal Novák, Bratislava, SK;

Eva Kontseková, Senec, SK;

Branislav Kovácech, Bratislava, SK;

Norbert Zilka, Senec, SK;

Assignee:

Axon Neuroscience SE, Larnaca, CY;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/00 (2006.01); G01N 33/68 (2006.01); C07K 14/47 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); G01N 33/53 (2006.01); A61K 49/00 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 38/1709 (2013.01); A61K 39/0007 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/6843 (2017.08); A61K 47/6849 (2017.08); A61K 49/0004 (2013.01); C07K 14/4711 (2013.01); G01N 33/53 (2013.01); G01N 33/6896 (2013.01); A61K 2039/505 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/6081 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/70 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/52 (2013.01);
Abstract

The invention provides unique therapeutic and diagnostic antibodies, as well as their fragments, portions, derivatives, and variants thereof, that bind regions of the tau protein that contribute to the initiation and propagation of pathological tau-tau interactions, as well as methods of making them. The invention also relates to methods of using those antibodies for diagnostics, prevention, and treatment of Alzheimer's disease and related tauopathies. The present invention also provides a method for a prophylactic and therapeutic treatment of Alzheimer's disease and other neurodegenerative tauopathies. This method entails the injection of antibodies and/or peptide vaccines that elicits an immune response directed to pathological tau proteins and tau deposits in the brains of patients. Suitable vaccines represent a tau peptide carrying one or more of the tau therapeutic epitopes provided herein.


Find Patent Forward Citations

Loading…